A Hierarchical Free Energy Framework for Ranking CDK Inhibitors: From PMF Barriers to Alchemical Precision
International Journal of Research · 30.05.2026 · 378
DOI: 10.26643/ijr/79 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Research, online erschienen am 30.05.2026. Verfasst von Ganga Graziela Christina und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Accurate prediction of binding free energies for structurally homologous kinase targets remains one of the most challenging tasks in computational drug discovery. CDK1 and CDK2 provide an exceptionally stringent benchmark: their active sites differ by only 0.72 Å backbone RMSD, yet experimental ITC data reveal up to 170-fold selectivity differences for certain inhibitors, corresponding to a ΔΔG of only 2.87 kcal/mol, which is smaller than the typical error of most computational methods. Here we establish and validate a three-tier hierarchical free energy protocol applied to five CDK–inhibitor complexes (Dinaciclib, AZD5438, and CGP74514A bound to CDK1 and CDK2). Tier 1 (MM/PBSA endpoint calculations) achieves a qualitative affinity ranking but fails quantitatively, yielding R ≈ 0.45 and a critical rank inversion for CDK2-Dinaciclib.
Zitieren
APA
Christina, G. G., & qu, C. (2026). A Hierarchical Free Energy Framework for Ranking CDK Inhibitors: From PMF Barriers to Alchemical Precision. International Journal of Research, 378. https://doi.org/10.26643/ijr/79
Vancouver
Christina GG, qu C. A Hierarchical Free Energy Framework for Ranking CDK Inhibitors: From PMF Barriers to Alchemical Precision. International Journal of Research. 2026:378. doi:10.26643/ijr/79
BibTeX
@article{Christina2026,
author = {Christina, Ganga Graziela and qu, Chen},
title = {A Hierarchical Free Energy Framework for Ranking CDK Inhibitors: From PMF Barriers to Alchemical Precision},
journal = {International Journal of Research},
year = {2026},
pages = {378},
doi = {10.26643/ijr/79}
}
EUVIMED